Medivir

About:

Medivir is a research-based pharmaceutical company with a research focus on oncology and infectious diseases.

Website: https://www.medivir.com

Twitter/X: medivir

Top Investors: Linc

Description:

Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. Medivir is a protease inhibitor design and the nucleotide/nucleoside science and we are dedicated to developing innovative pharmaceuticals that meet a great unmet medical need. Our commercial organization provides a portfolio of specialty care, pharmaceuticals on the Nordic market.

Total Funding Amount:

$45.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Stockholm, Stockholms Lan, Sweden

Founded Date:

1988-01-01

Contact Email:

info(AT)medivir.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-10-24

IPO Status:

Public

Industries:

© 2025 bioDAO.ai